What is the preferred contraceptive method for a young woman who smokes?

Preferred Contraceptive Method for a Young Woman Who Smokes

For a young woman who smokes, long-acting reversible contraceptives (LARCs) such as the levonorgestrel IUD or etonogestrel implant are the preferred first-line options, as they avoid the increased thrombotic risks associated with estrogen-containing methods in smokers.

Risk Stratification by Age and Smoking Intensity

The critical factor determining contraceptive safety in smokers is age and cigarette consumption:

• Under 35 years old: Combined hormonal contraceptives (CHCs) containing estrogen are generally acceptable (Category 2), though not ideal 1
• 35 years or older who smoke <15 cigarettes/day: CHCs are usually not recommended (Category 3) 1
• 35 years or older who smoke ≥15 cigarettes/day: CHCs represent an unacceptable health risk (Category 4) and should not be used 1

Since this patient is described as "young" (presumably under 35), she falls into the first category where estrogen-containing methods are not absolutely contraindicated but carry increased risk.

Recommended Contraceptive Hierarchy

First-Line: Progestin-Only LARCs

• Levonorgestrel IUD (Mirena) or etonogestrel implant (Implanon)
• These methods avoid estrogen entirely, eliminating thrombotic risk from smoking
• Highest efficacy (<1% failure rate with perfect use)
• Do not require daily adherence
• No drug interactions with smoking

Second-Line: Other Progestin-Only Methods

• Injectable DMPA (Depo-Provera): 9% typical-use failure rate 2
• Progestin-only pills (POPs): Less effective than combined methods, require strict timing (must be taken within same 3-hour window daily) 3

Third-Line: Combined Hormonal Contraceptives (if above methods unavailable/unacceptable)

If the patient strongly prefers or requires a combined method and is under 35:

• Lowest estrogen dose formulations (20 μg ethinyl estradiol) may be safer 4, 5
• Research suggests third-generation progestins (desogestrel or gestodene) with low-dose estrogen may have lower arterial thrombotic risk in smokers 4
• However, the transdermal patch should be avoided due to 1.6 times higher estrogen exposure and increased VTE risk 3

Critical Counseling Points

Synergistic thrombotic risk: The combination of smoking and estrogen-containing contraceptives creates a synergistic effect on myocardial infarction and stroke risk (though not venous thromboembolism) 4. This multiplicative rather than additive risk is the primary concern.

Smoking cessation is paramount: Every visit should include assessment of smoking status and active encouragement to quit 5. Smoking cessation eliminates the contraindication and substantially reduces cardiovascular risk.

Barrier method necessity: Regardless of hormonal method chosen, condoms should be used consistently for STI protection, as no hormonal method prevents sexually transmitted infections 3.

Common Pitfalls to Avoid

1. Don't assume all smokers are the same: A 22-year-old smoking 5 cigarettes/day has vastly different risk than a 38-year-old smoking a pack daily
2. Don't prescribe the patch to smokers: The higher estrogen exposure makes this particularly problematic 3
3. Don't forget about DMPA bone density concerns: While DMPA is safe regarding thrombosis, counsel about calcium (1300 mg daily) and vitamin D (600 IU daily) supplementation 2
4. Don't overlook lipid screening: For smokers over 35 requesting CHCs, consider lipid profile assessment 5

Practical Implementation

For this "novice" young woman (suggesting limited contraceptive experience):

• Start with shared decision-making about LARCs, emphasizing their superior efficacy and safety profile
• If she declines LARCs and is under 35, progestin-only pills or DMPA are reasonable alternatives
• If she insists on combined methods and is under 35, use the lowest estrogen dose available (20 μg ethinyl estradiol)
• Provide emergency contraception counseling and advance prescription for levonorgestrel 3
• Schedule 1-3 month follow-up to address adherence and side effects 2